This enhanced expression of adaptive immune response genes, characterized by B and T cell markers, as well as inflammasome activation and Il1b, Il6, and Tnf expression (Figure 3E), has all the features of the low-grade inflammation characteristic of CKD (28, 29). This evidence concerns the gene IL6 and chronic kidney disease.